CYTK

Cytokinetics, Incorporated

1CYTK
USA
NASDAQ

$69.04

24H

1.53%

Market Cap

7.2 B

Volume

791.8 K

Supply

104.6 M

Price Chart

About Cytokinetics, Incorporated - CYTK

Cytokinetics, Incorporated is a biopharmaceutical company focused on the discovery, development, and commercialization of novel small-molecule drugs that modulate muscle function for the potential treatment of serious diseases and medical conditions. Their research primarily addresses the muscle systems, such as cardiac and skeletal muscles.

What are Cytokinetics, Incorporated's core values and mission statement?

Cytokinetics, Incorporated is a biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised. Their core mission is to improve the healthspan of people suffering from severe diseases characterized by impaired muscle function.

Who founded Cytokinetics, Incorporated and when?

Cytokinetics, Incorporated was founded by James Spudich, Lawrence S.B. Goldstein, and Ronald D. Vale in 1997.

Who leads Cytokinetics, Incorporated?

As of the time this information was last verified, Cytokinetics, Incorporated was led by Robert I. Blum, who served as the company's President and Chief Executive Officer.

Where is Cytokinetics, Incorporated located, and what is its base country?

Cytokinetics, Incorporated is headquartered in South San Francisco, California, United States.

On which exchanges is Cytokinetics, Incorporated traded?

Cytokinetics, Incorporated is traded on the Nasdaq Stock Market under the ticker symbol CYTK.

Historical data

1D
5D
1M
6M
1Y
MAX
Day
Open/Close
Low/High
Volume
Cap

Cytokinetics, Incorporated (CYTK) Price Live Data

The live price of Cytokinetics, Incorporated (CYTK) is $69.04, with a trading volume of 791,847 in the last 24 hours. Wrapstocks updates the CYTK price in real-time. Cytokinetics, Incorporated is up 1.53% in the last 24 hours. The company has a live market cap of $7,219,927,040.00 and a supply of 104,576,000 CYTK stocks.

Cytokinetics, Incorporated (CYTK) is traded on NASDAQ Stock Exchange, and currently, the market is closed; trading will be resumed in 13 hours and 25 minutes.

Exchange
NASDAQ
NASDAQ
NASDAQ Stock Exchange
USA
Opens in
13 hours and 25 minutes
Working Hours
Mon-Fri, 01:30 PM - 08:00 PM
Timezone
GMT+0
Last Updated
16 Apr 2024 07:56 PM